2,461 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Capital Market Strategies LLC

Capital Market Strategies LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,461 shares of the healthcare conglomerate’s stock, valued at approximately $1,183,000. UnitedHealth Group makes up 1.1% of Capital Market Strategies LLC’s portfolio, making the stock its 18th biggest position.

Several other hedge funds also recently made changes to their positions in UNH. Chelsea Counsel Co. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $27,000. 25 LLC bought a new position in shares of UnitedHealth Group in the first quarter valued at $28,000. Freedom Wealth Alliance LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $31,000. Cascade Investment Advisors Inc. bought a new position in shares of UnitedHealth Group in the first quarter valued at $28,000. Finally, Kalos Management Inc. acquired a new stake in UnitedHealth Group during the 1st quarter valued at $34,000. 85.69% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $486.70 on Friday. The stock’s 50-day moving average is $491.55 and its 200-day moving average is $486.55. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. The stock has a market cap of $450.83 billion, a P/E ratio of 21.78, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, topping analysts’ consensus estimates of $5.92 by $0.22. The company had revenue of $92.90 billion for the quarter, compared to analyst estimates of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The firm’s quarterly revenue was up 15.6% on a year-over-year basis. During the same period in the previous year, the firm earned $5.57 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 24.83 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Friday, September 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 33.65%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the transaction, the chief executive officer now directly owns 78,573 shares of the company’s stock, valued at $39,772,866.87. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

UNH has been the subject of several research reports. Piper Sandler initiated coverage on UnitedHealth Group in a report on Thursday, May 25th. They set an “overweight” rating and a $580.00 price target for the company. UBS Group lifted their target price on UnitedHealth Group from $510.00 to $520.00 and gave the stock a “neutral” rating in a report on Wednesday, July 19th. StockNews.com initiated coverage on UnitedHealth Group in a research note on Thursday, August 17th. They issued a “buy” rating for the company. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $527.00 to $532.00 and gave the company an “overweight” rating in a research note on Monday, July 17th. Finally, Sanford C. Bernstein upgraded UnitedHealth Group from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $595.00 to $603.00 in a research report on Tuesday, July 18th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $575.65.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.